Risk assessment in haematopoietic stem cell transplantation: Viral status

被引：30
作者：
Ljungman, Per [1 ]
机构：
[1] Karolinska Inst, Karolinska Univ Hosp, Hematol Ctr, SE-14186 Stockholm, Sweden
来源：
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY | 2007年 / 20卷 / 02期
关键词：
viral infections; serology; CMV; stem-cell transplantation; donors;
D O I：
10.1016/j.beha.2006.09.003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Viral infections have been important complications in the transplant procedure from the early days of stem-cell transplantation, causing significant morbidity and mortality. It is important for the management of patients to assess the risk for viral infections that might develop after the stem-cell transplantation. This can be exemplified by cytomegalovirus (CMV) and other herpesviruses, but risk assessment is also important for other viral infections. The aim of this review is to describe current knowledge regarding recipient and donor serological status for viral infections.
引用
收藏
页码：209 / 217
页数：9
相关论文
共 40 条
  • [1] Eradication of virus-infected T-cells in a case of adult T-cell leukemia/lymphoma by nonmyeloablative peripheral blood stem cell transplantation with conditioning consisting of low-dose total body irradiation and pentostatin
    Abe, Y
    Yashiki, S
    Choi, I
    Hara, K
    Matsushima, T
    Nishimura, J
    Inaba, S
    Nawata, H
    Muta, K
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 76 (01) : 91 - 93
  • [2] Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation - a randomized double-blind placebo-controlled study
    Boeckh, M
    Kim, HW
    Flowers, MED
    Meyers, JD
    Bowden, RA
    [J]. BLOOD, 2006, 107 (05) : 1800 - 1805
  • [3] The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy
    Boeckh, M
    Nichols, WG
    [J]. BLOOD, 2004, 103 (06) : 2003 - 2008
  • [4] STRONG DONOR MONONUCLEAR CELL REACTIVITY FOR HERPES-SIMPLEX VIRUS (HSV) ANTIGEN IN HSV IMMUNE DONORS COMBINED WITH RECIPIENT SEROPOSITIVITY FOR HSV IS ASSOCIATED WITH ACUTE GRAFT-VERSUS-HOST DISEASE
    BOSTROM, L
    RINGDEN, O
    FORSGREN, M
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1991, 34 (01) : 45 - 52
  • [5] BOSTROM L, 1990, TRANSPLANT P, V22, P206
  • [6] CYTOMEGALOVIRUS IMMUNE GLOBULIN AND SERONEGATIVE BLOOD PRODUCTS TO PREVENT PRIMARY CYTOMEGALOVIRUS-INFECTION AFTER MARROW TRANSPLANTATION
    BOWDEN, RA
    SAYERS, M
    FLOURNOY, N
    NEWTON, B
    BANAJI, M
    THOMAS, ED
    MEYERS, JD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (16) : 1006 - 1010
  • [7] West Nile Virus encephalopathy in an allogeneic stem cell transplant recipient: use of quantitative PCR for diagnosis and assessment of viral clearance (vol 36, pg 369, 2005)
    Brenner, W
    Storch, G
    Buller, R
    Vij, R
    Devine, S
    DiPersio, J
    [J]. BONE MARROW TRANSPLANTATION, 2005, 36 (04) : 369 - 370
  • [8] Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation
    Broers, AEC
    van der Holt, R
    van Esser, JWJ
    Gratama, JW
    Henzen-Logmans, S
    Kuenen-Boumeester, V
    Löwenberg, B
    Cornelissen, JJ
    [J]. BLOOD, 2000, 95 (07) : 2240 - 2245
  • [9] Cytomegalovirus seropositivity adversely influences outcome after T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft-versus-host disease prophylaxis
    Craddock, C
    Szydlo, RM
    Dazzi, F
    Olavarria, E
    Cwynarski, K
    Yong, A
    Brookes, P
    de la Fuente, J
    Kanfer, E
    Apperley, JF
    Goldman, JM
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (01) : 228 - 236
  • [10] CRAY C, 1992, TRANSPLANTATION, V53, P696
1234